MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$257,837K Short-term investments$153,756K Prepaid and othercurrent assets$7,727K Total current assets$419,320K Goodwill$19,918K Other non-currentassets$862K Total assets$440,100K Total liabilities andshareholders' equity$440,100K Total shareholders'equity$332,327K Total liabilities$107,773K Accumulated deficit-$582,672K Additional paid-in capital$913,914K Total currentliabilities$66,698K Credit facility,long-term$40,579K Other non-currentliabilities$496K Accumulated othercomprehensive income$1,085K 2022 usd financingwarrants$40,905K Accrued expenses$20,446K Accounts payable$5,347K
Balance Sheet
source: myfinsight.com

Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc. (DFTX)